These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19089691)

  • 1. Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres.
    Veerareddy PR; Vobalaboina V; Ali N
    J Drug Target; 2009 Feb; 17(2):140-7. PubMed ID: 19089691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of oil-in-water emulsions of piperine in visceral leishmaniasis.
    Veerareddy PR; Vobalaboina V; Nahid A
    Pharmazie; 2004 Mar; 59(3):194-7. PubMed ID: 15074591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.
    Asthana S; Gupta PK; Jaiswal AK; Dube A; Chourasia MK
    Nanomedicine (Lond); 2015; 10(7):1093-109. PubMed ID: 25929567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.
    Gupta S; Dube A; Vyas SP
    J Drug Target; 2007 Jul; 15(6):437-44. PubMed ID: 17613662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpressed Macrophage Mannose Receptor Targeted Nanocapsules- Mediated Cargo Delivery Approach for Eradication of Resident Parasite: In Vitro and In Vivo Studies.
    Asthana S; Gupta PK; Jaiswal AK; Dube A; Chourasia MK
    Pharm Res; 2015 Aug; 32(8):2663-77. PubMed ID: 25715698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis.
    Voak AA; Harris A; Qaiser Z; Croft SL; Seifert K
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.
    Mullen AB; Carter KC; Baillie AJ
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2089-92. PubMed ID: 9333030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.
    Asad M; Bhattacharya P; Banerjee A; Ali N
    BMC Infect Dis; 2015 Apr; 15():188. PubMed ID: 25884796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid formulations of amphotericin b in the treatment of experimental visceral leishmaniasis due to Leishmania infantum.
    Gangneux JP; Sulahian A; Garin YJ; Derouin F
    Trans R Soc Trop Med Hyg; 1996; 90(5):574-7. PubMed ID: 8944278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
    Kar N; Chakraborty S; De AK; Ghosh S; Bera T
    Eur J Pharm Sci; 2017 Jun; 104():196-211. PubMed ID: 28400285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and
    Iman M; Huang Z; Alavizadeh SH; Szoka FC; Jaafari MR
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired Calcium Phosphate Nanoparticles Featuring as Efficient Carrier and Prompter for Macrophage Intervention in Experimental Leishmaniasis.
    Chaurasia M; Singh PK; Jaiswal AK; Kumar A; Pawar VK; Dube A; Paliwal SK; Chourasia MK
    Pharm Res; 2016 Nov; 33(11):2617-29. PubMed ID: 27401407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
    Gupta PK; Jaiswal AK; Asthana S; Verma A; Kumar V; Shukla P; Dwivedi P; Dube A; Mishra PR
    Pharm Res; 2015 May; 32(5):1727-40. PubMed ID: 25425053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
    Al-Abdely HM; Graybill JR; Loebenberg D; Melby PC
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2910-4. PubMed ID: 10582881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis.
    Khatik R; Dwivedi P; Khare P; Kansal S; Dube A; Mishra PR; Dwivedi AK
    Expert Opin Drug Deliv; 2014 May; 11(5):633-46. PubMed ID: 24606222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
    Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
    Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploitation of lectinized lipo-polymerosome encapsulated Amphotericin B to target macrophages for effective chemotherapy of visceral leishmaniasis.
    Gupta PK; Asthana S; Jaiswal AK; Kumar V; Verma AK; Shukla P; Dwivedi P; Dube A; Mishra PR
    Bioconjug Chem; 2014 Jun; 25(6):1091-102. PubMed ID: 24842628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis.
    Rathore A; Jain A; Gulbake A; Shilpi S; Khare P; Jain A; Jain SK
    J Liposome Res; 2011 Dec; 21(4):333-40. PubMed ID: 21612342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
    Shahnaz G; Edagwa BJ; McMillan J; Akhtar S; Raza A; Qureshi NA; Yasinzai M; Gendelman HE
    Nanomedicine (Lond); 2017 Jan; 12(2):99-115. PubMed ID: 27879160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.